Software As A Medical Device (SaMD) Market Growth Through 2030 Creates New Strategic Opportunities
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The software as a medical device (SaMD) sector has witnessed remarkable expansion recently, driven by technological advancements and changing healthcare needs. As digital health solutions become more integrated into medical practices, this market is set for significant growth in the coming years. Here, we explore the current market size, key growth factors, segmentation, industry trends, major players, and regional insights shaping the future of SaMD.
Steady Market Growth and Revenue Projections for Software as a Medical Device
The SaMD market has experienced rapid growth in recent times. From a valuation of $38.02 billion in 2025, it is expected to rise to $47.26 billion in 2026, reflecting an impressive compound annual growth rate (CAGR) of 24.3%. This growth during the historical period has been fueled by the widespread adoption of telemedicine, increased smartphone usage, substantial digital health investments, clearer regulations, and a growing demand for remote healthcare services. Looking ahead, the market is predicted to expand even more dramatically, reaching $120.54 billion by 2030 at a CAGR of 26.4%. This surge is anticipated to be supported by the expanding virtual care sector, advances in software-driven diagnostics, the adoption of cloud-based healthcare platforms, outcome-based reimbursement models, and modernization of hospital software systems. Emerging trends during this forecast period include the growth of clinical decision support software, increased use of remote diagnostic tools, enhanced regulatory approvals for medical software, subscription-based business models for SaMD, and greater integration with electronic health records.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12446&type=smp
Key Factors Propelling Growth in the Software as a Medical Device Market
One of the main drivers behind the expanding SaMD market is the rising prevalence of chronic diseases. Conditions such as diabetes, heart disease, and arthritis are long-term illnesses that generally worsen over time, requiring continuous medical management and lifestyle adjustments. The increase in chronic diseases can largely be attributed to unhealthy habits including poor nutrition, lack of physical activity, and smoking, which elevate risks for diabetes, cardiovascular issues, and obesity. SaMD technologies play an important role by enabling constant monitoring of patient health metrics, facilitating early identification of potential complications. This continuous oversight improves treatment results through personalized guidance and supports remote care, reducing the need for frequent hospital visits. For example, in June 2024, the National Health Service in the UK reported that 3,615,330 people registered with a general practitioner had non-diabetic hyperglycemia or pre-diabetes in 2023, which is an 18% increase from 3,065,825 cases in 2022. This upward trend in chronic disease incidence is a strong catalyst for SaMD market growth.
Detailed Breakdown of Software as a Medical Device Market Segments
The SaMD market is categorized into several key segments for better clarity:
1) Device Type: Wearable Devices, PCs and Laptops, Smartphones and Tablets
2) Deployment Method: Cloud-Based and On-Premise solutions
3) Application Area: Diagnostic and Clinical Management
Access The Complete Software As A Medical Device (SaMD) Market Report:
Further subcategories include:
– Wearable Devices such as smartwatches with health monitoring features, fitness trackers, and wearable ECG and blood pressure monitors
– PCs and Laptops featuring medical diagnostic software, clinical decision support systems, and telemedicine platforms
– Smartphones and Tablets hosting mobile health (mHealth) applications, remote patient monitoring software, and diagnostic imaging apps
Emerging Trends Shaping the Future of the SaMD Market
Leading companies in the SaMD industry are heavily investing in cutting-edge software to gain a competitive advantage. A notable example is SOMNUM, an advanced sleep disorder analysis software that combines the latest artificial intelligence (AI) research with diagnostic algorithms based on multi-channel sleep biosignal data rather than traditional video images. In September 2023, South Korean firm HoneyNaps Co. Ltd. received approval from the United States Food and Drug Administration (USFDA) for SOMNUM. This software utilizes deep learning AI to analyze various biosignals in real time—such as electroencephalograms, electrooculograms, electromyograms, electrocardiograms, respiratory airflow and effort, and oxygen saturation. It offers higher precision than conventional techniques and dramatically reduces the time needed for patient sleep data analysis to less than five minutes.
Leading Industry Players Driving Innovation in SaMD
Some of the major organizations active in the software as a medical device market include Apple Inc., Abbott Laboratories, Siemens Healthcare GmbH, GE HealthCare Technologies Inc., Roche Diagnostics, Cerner Corporation, Philips Medical Systems Ltd., Dexcom Inc., Carl Zeiss Meditec AG, Nihon Kohden Corporation, Viz.ai Inc., S3 Connected Health, Arterys Inc., BrightInsight Inc., Agfa HealthCare Corp., iSchemaView Inc., VitalConnect Inc., Volpara Health Technologies, Greenfinch Technology Ltd., MaxQ AI Ltd., and IDx Technologies Inc.
Regional Market Insights Highlighting Growth Opportunities
In 2025, North America held the largest share of the SaMD market. However, the Asia-Pacific region is expected to grow at the fastest pace during the forecast period. The comprehensive market overview includes key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on emerging trends and growth prospects.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
